Go Pro
NASDAQ:MODD

Modular Medical Q1 2027 Earnings Report

Modular Medical logo
$1.92 -0.10 (-4.73%)
As of 12:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Modular Medical EPS Results

Actual EPS
-$1.19
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Modular Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Modular Medical Announcement Details

Quarter
Q1 2027
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Modular Medical's next earnings date is estimated for Wednesday, December 2, 2026, based on past reporting schedules.

Conference Call Resources

Modular Medical Earnings Headlines

Modular Medical (NASDAQ:MODD) Shares Up 2.3% - Here's What Happened
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
Modular Medical Corporate Event Calendar | NASDAQ:MODD
See More Modular Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Modular Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Modular Medical and other key companies, straight to your email.

About Modular Medical

Modular Medical (NASDAQ:MODD) (NASDAQ:MODD) is a medical device company focused on developing and commercializing insulin-delivery technologies for people with diabetes. The company’s primary product is the MODD1 insulin pump, a wearable device designed to provide continuous subcutaneous insulin infusion.

The MODD1 system is intended to offer a simpler and more accessible alternative to traditional insulin pumps. Modular Medical has emphasized ease of use, streamlined operation and affordability as key elements of its product-development strategy, with the goal of expanding access to pump therapy among people who use insulin.

Modular Medical is based in the United States and has focused its development and regulatory efforts on the U.S. diabetes-care market. The company remains primarily centered on advancing the MODD1 platform and building the capabilities needed for its commercialization.

View Modular Medical Profile